R&D Approach

An access to Roche’s R&D

For 125 years, Roche has evolved medicine through pioneering innovation for the benefit of patients. With its unique R&D ecosystem, supported by the Institut Roche, Roche is a global healthcare leader, providing patients with life-changing solutions.

Roche’s success in figures, past and present

Throughout its history, the Roche Group has received many awards testifying to its scientific excellence:

43

Prix Galien

since 1970

38

Breakthrough Therapy Designations

from the FDA between 2013 and 2022

4

PRIME designations

from the European Union

Roche is the world’s leading investor in healthcare Research & Development:

14.8

Billions Swiss francs

of budget for R&D in 2021

1.4

Millions euros spent

on R&D every hour, every day of 2021: our R&D expenditure of 13.7 billion Swiss francs (+14%) last year already exceeds that of any other healthcare company worldwide.

…Voir plus Voir moins

21.8%

PRIME designations

of turnover invested in R&D

0

No biosimilars

since 1970

80

exceptional therapeutic solutions

in the pipeline

Video

Frédéric de Sauvage

Frédéric de Sauvage, VP Research Molecular Oncology , speaks about the challenges of the molecular oncology research at Genentech

Video

Andrew Chan

Andrew Chan, SVP in Research Biology, answers 3 questions about how Big Data approach impacts gene identification and analysis in biomedical research

The Roche ecosystem:
fostering R&D for groundbreaking innovation

At the heart of the Roche R&D, the Institut Roche streamlines innovation by connecting and supporting all the Roche autonomous and synergic poles. Together, those divisions build an ecosystem of outstanding expertise, connecting with hundreds of external partners.